share_log

ModivCare Insiders Are Down US$82k But Regain Some Losses

モディブケア社の内部関係者は82,000ドル減少しましたが、一部の損失を回復しています。

Simply Wall St ·  05/09 06:16

Insiders who purchased US$226.4k worth of ModivCare Inc. (NASDAQ:MODV) shares over the past year recouped some of their losses after price gained 18% last week. However, total losses seen by insiders are still US$82k since the time of purchase.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

ModivCare Insider Transactions Over The Last Year

The CEO, President L. Sampson made the biggest insider purchase in the last 12 months. That single transaction was for US$121k worth of shares at a price of US$34.57 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$26.28). It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. The only individual insider to buy over the last year was L. Sampson.

L. Sampson bought a total of 5.50k shares over the year at an average price of US$41.16. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
NasdaqGS:MODV Insider Trading Volume May 9th 2024

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data suggests ModivCare insiders own 1.1% of the company, worth about US$4.2m. I generally like to see higher levels of ownership.

What Might The Insider Transactions At ModivCare Tell Us?

It doesn't really mean much that no insider has traded ModivCare shares in the last quarter. However, our analysis of transactions over the last year is heartening. We'd like to see bigger individual holdings. However, we don't see anything to make us think ModivCare insiders are doubting the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 2 warning signs for ModivCare you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする